Cargando…

Predictive Biomarkers of Age-Related Macular Degeneration Response to Anti-VEGF Treatment

Age-related macular degeneration (AMD) is an incurable disease associated with aging that destroys sharp and central vision. Increasing evidence implicates both systemic and local inflammation in the pathogenesis of AMD. Intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oca, Ana I., Pérez-Sala, Álvaro, Pariente, Ana, Ochoa, Rodrigo, Velilla, Sara, Peláez, Rafael, Larráyoz, Ignacio M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706948/ https://www.ncbi.nlm.nih.gov/pubmed/34945801 http://dx.doi.org/10.3390/jpm11121329

Ejemplares similares

Biomarkers as Predictive Factors of Anti-VEGF Response
por: Bobadilla, Miriam, et al.
Publicado: (2022)

Genome-Wide Transcriptomic Analysis Identifies Pathways Regulated by Sterculic Acid in Retinal Pigmented Epithelium Cells
por: Pariente, Ana, et al.
Publicado: (2020)

Sterculic Acid Alters Adhesion Molecules Expression and Extracellular Matrix Compounds to Regulate Migration of Lung Cancer Cells
por: Peláez, Rafael, et al.
Publicado: (2021)

Integrins: Moonlighting Proteins in Invadosome Formation
por: Peláez, Rafael, et al.
Publicado: (2019)

Sterculic Acid: The Mechanisms of Action beyond Stearoyl-CoA Desaturase Inhibition and Therapeutic Opportunities in Human Diseases
por: Peláez, Rafael, et al.
Publicado: (2020)

Identification of 7-Ketocholesterol-Modulated Pathways and Sterculic Acid Protective Effect in Retinal Pigmented Epithelium Cells by Using Genome-Wide Transcriptomic Analysis
por: Pariente, Ana, et al.
Publicado: (2023)

Targeting 7KCh-Induced Cell Death Response Mediated by p38, P2X7 and GSDME in Retinal Pigment Epithelium Cells with Sterculic Acid
por: Pariente, Ana, et al.
Publicado: (2023)

Genetic biomarkers in the VEGF pathway predicting response to anti-VEGF therapy in age-related macular degeneration
por: Balikova, Irina, et al.
Publicado: (2019)

New Approach of Anti-VEGF Agents for Age-Related Macular Degeneration
por: Park, Young Gun, et al.
Publicado: (2012)

Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
por: García-Quintanilla, Laura, et al.
Publicado: (2019)

Application and mechanism of anti-VEGF drugs in age-related macular degeneration
por: Song, Dawei, et al.
Publicado: (2022)

Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
por: Kaiser, Stephanie M, et al.
Publicado: (2021)

Individual recurrence intervals after anti-VEGF therapy for age-related macular degeneration
por: Hörster, Robert, et al.
Publicado: (2010)

Therapeutic Effect of Anti-VEGF for Age-Related Macular Degeneration in the Untreated Fellow Eye
por: Isildak, Hacer, et al.
Publicado: (2018)

Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration
por: Pfau, Maximilian, et al.
Publicado: (2021)

Understanding patient preferences in anti-VEGF treatment options for age-related macular degeneration
por: Ozdemir, Semra, et al.
Publicado: (2022)

Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration
por: Wykoff, Charles C., et al.
Publicado: (2018)

Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
por: Kabanarou, Stamatina A, et al.
Publicado: (2017)

Brolucizumab for persistent macular fluid in neovascular age-related macular degeneration after prior anti-VEGF treatments
por: Hussain, Rehan M., et al.
Publicado: (2021)

Treatment of neovascular age-related macular degeneration with anti-VEGF agents: retrospective analysis of 5-year outcomes
por: Pedrosa, Ana Catarina, et al.
Publicado: (2016)

Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes
por: Pedrosa, Ana Catarina, et al.
Publicado: (2017)

Exploring the role of VEGF in Indian Age related macular degeneration
por: Sharma, Kaushal, et al.
Publicado: (2015)

Psychological impact of anti-VEGF treatments for wet macular degeneration—a review
por: Senra, Hugo, et al.
Publicado: (2016)

Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration
por: Davis, R Prince, et al.
Publicado: (2010)

Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review
por: Yang, Shiqi, et al.
Publicado: (2016)

Effect of anti-VEGF drugs combined with photodynamic therapy in the treatment of age-related macular degeneration
por: Dong, Yi, et al.
Publicado: (2016)

Subjective health expectations of patients with age-related macular degeneration treated with antiVEGF drugs
por: Péntek, Márta, et al.
Publicado: (2017)

Response of eyes with age-related macular degeneration to anti-VEGF drugs and implications for therapy planning
por: Miyamoto, Noriko, et al.
Publicado: (2017)

Genetic Association Analysis of Anti-VEGF Treatment Response in Neovascular Age-Related Macular Degeneration
por: Strunz, Tobias, et al.
Publicado: (2022)

Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degeneration
por: Hirata, Akira, et al.
Publicado: (2017)

Combinatorial treatment with topical NSAIDs and anti-VEGF for age-related macular degeneration, a meta-analysis
por: Li, Songshan, et al.
Publicado: (2017)

Correlation of Baseline Visual Acuity with Outcomes of Treatment with Anti-VEGF in Neovascular Age-Related Macular Degeneration
por: Veluswamy, Balaji, et al.
Publicado: (2020)

Aqueous humour proteins and treatment outcomes of anti-VEGF therapy in neovascular age-related macular degeneration
por: Arai, Yusuke, et al.
Publicado: (2020)

Quantitative assessment of retinal fluid in neovascular age-related macular degeneration under anti-VEGF therapy
por: Reiter, Gregor S., et al.
Publicado: (2022)

Pachychoroid Neovasculopathy Disguising as Age-Related Macular Degeneration Treated by Spironolactone and Anti-VEGF Combination Therapy
por: Keidel, Leonie F., et al.
Publicado: (2021)

The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF
por: Han, Fangyuan, et al.
Publicado: (2022)

Retinal layers changes in patients with age-related macular degeneration treated with intravitreal anti-VEGF agents
por: Zhou, Dan, et al.
Publicado: (2023)

Changes in neurophysiologic markers of visual processing following beneficial anti-VEGF treatment in macular degeneration
por: Vottonen, Pasi, et al.
Publicado: (2013)

A pharmacogenetics study to predict outcome in patients receiving anti-VEGF therapy in age related macular degeneration
por: Kitchens, John W, et al.
Publicado: (2013)

Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy
por: Prea, Selwyn M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_26av6miggjo3620ejqo804f7rh